P. Csurhes

发表

VARIATION IN THE VITAMIN D RECEPTOR GENE IS ASSOCIATED WITH MULTIPLE SCLEROSIS IN AN AUSTRALIAN POPULATION

R. Lea, L. Griffiths, Matthew P Johnson, 2005, Journal of neurogenetics.

Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population

L. Griffiths, M. Pender, N. Colson, 2007, Journal of the Neurological Sciences.

Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis

J. Burrows, S. Burrows, M. Pender, 2017, Clinical & translational immunology.

and Lesion Localization in Multiple SclerosisType Reactivity to Myelin Proteins with HLA Correlation of Blood T Cell and Antibody

M. Pender, J. Greer, P. Csurhes, 2008 .

Healthy Subjects Patients with Multiple Sclerosis Than in Proteolipid Protein Occur More Often in Encephalitogenic Region of Myelin Surges of Increased T Cell Reactivity to an

M. Pender, D. Purdie, M. Good, 2000 .

Investigation of the [−/A]8 and C1236T genetic variations within the human toll-like receptor 3 gene for association with multiple sclerosis

L. Griffiths, M. Pender, J. Mackenzie, 2010, Neurological research.

Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy

P. Mccombe, P. Csurhes, H. Inglis, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndrome

M. Pender, P. Mccombe, A. Sullivan, 2005, Journal of Clinical Neuroscience.

T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy

M. Pender, P. Mccombe, A. Sullivan, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

polyradiculoneuropathy chronic inflammatory demyelinating and protein in patients with Guillain-Barré syndrome T cell reactivity to P0, P2, PMP-22, and myelin basic

M. Pender, P. Mccombe, P. Csurhes, 2005 .

Studies of HLA associations in male and female patients with Guillain–Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

P. Mccombe, J. Greer, P. Csurhes, 2006, Journal of Neuroimmunology.

T cells from patients with Guillain-Barré syndrome produce interferon-gamma in response to stimulation with the ganglioside GM1

P. Mccombe, P. Csurhes, 2010, Journal of Clinical Neuroscience.

Killer immunoglobulin-like receptor and their HLA ligands in Guillain–Barré Syndrome

P. Mccombe, J. Spies, S. Blum, 2014, Journal of Neuroimmunology.

Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis

S. Burrows, M. Pender, P. Csurhes, 2014, Multiple sclerosis.

Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis

A. Coulthard, S. Burrows, R. Khanna, 2014, Multiple sclerosis.

Amino acid sequences recognized by T cells: studies on a merozoite surface antigen from the FCQ-27/PNG isolate of Plasmodium falciparum.

C. Rzepczyk, E. Baxter, D. Irving, 1990, Immunology letters.

Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population

R. Lea, L. Griffiths, M. Pender, 2004, Brain Research Bulletin.

No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort

L. Griffiths, N. Colson, J. Fowdar, 2007, Journal of the Neurological Sciences.

Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls.

M. Pender, P. Mccombe, J. Greer, 2004, Journal of autoimmunity.

Surges of Increased T Cell Reactivity to an Encephalitogenic Region of Myelin Proteolipid Protein Occur More Often in Patients with Multiple Sclerosis Than in Healthy Subjects1

M. Pender, D. Purdie, M. Good, 2000, The Journal of Immunology.

A study of human T-cell lines generated from multiple sclerosis patients and controls by stimulation with peptides of myelin basic protein

R. Houghten, M. Pender, M. Good, 1996, Journal of Neuroimmunology.

Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis

S. Burrows, M. Pender, A. Lenarczyk, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Humoral immune responses of Solomon Islanders to the merozoite surface antigen 2 of Plasmodium falciparum show pronounced skewing towards antibodies of the immunoglobulin G3 subclass

A. Ferrante, C. Rzepczyk, A. Bobogare, 1997, Infection and immunity.

An investigation of the C77G and C772T variations within the human protein tyrosine phosphatase receptor type C gene for association with multiple sclerosis in an Australian population

L. Griffiths, M. Pender, J. Mackenzie, 2009, Brain Research.

Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis

J. Burrows, S. Burrows, M. Pender, 2017, Clinical & translational immunology.

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

Katherine K. Matthews, A. Coulthard, S. Burrows, 2020, JCI insight.

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

Pablo Moscato, Rodney J. Scott, Brian L. Browning, 2009, Nature Genetics.

The frequencies of Killer immunoglobulin-like receptors and their HLA ligands in chronic inflammatory demyelinating polyradiculoneuropathy are similar to those in Guillian Barre syndrome but differ from those of controls, suggesting a role for NK cells in pathogenesis

P. Mccombe, S. Blum, P. Csurhes, 2015, Journal of Neuroimmunology.

Interleukin-6 Gene Promoter-572 C Allele may Play a Role in Rate of Disease Progression in Multiple Sclerosis

Pamela A. McCombe, M. Pender, P. Mccombe, 2012, International journal of molecular sciences.

Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis

M. Pender, M. Good, P. Mccombe, 2003, Journal of Clinical Neuroscience.

Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis.

M. Pender, M. Good, P. Mccombe, 1997, Brain : a journal of neurology.

Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population

L. Griffiths, M. Pender, J. Mackenzie, 2009, Journal of the Neurological Sciences.

Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein–Barr Virus-Specific T Cell Therapy

A. Coulthard, M. Pender, Z. Ioannides, 2021, Frontiers in Neurology.

Correlation of Blood T Cell and Antibody Reactivity to Myelin Proteins with HLA Type and Lesion Localization in Multiple Sclerosis1

M. Pender, J. Greer, P. Csurhes, 2008, The Journal of Immunology.

Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism in a multiple sclerosis population

R. Lea, L. Griffiths, M. Pender, 2004, Journal of the Neurological Sciences.

Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: Effect on outcome

P. Mccombe, Jun Yan, J. Greer, 2015, Journal of Neuroimmunology.

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

Katherine K. Matthews, A. Coulthard, S. Burrows, 2020, JCI insight.

Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.

H. Matile, C. Rzepczyk, R. Lord, 1990, Journal of immunology.

Comparative study of the T cell response to two allelic forms of a malarial vaccine candidate protein.

A. Saul, C. Rzepczyk, G. Jones, 1992, Journal of immunology.

CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosis

S. Burrows, M. Pender, P. Csurhes, 2011, Journal of Neurology, Neurosurgery & Psychiatry.

Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis

P. Foubert, M. Pender, Z. Ioannides, 2021, Multiple sclerosis journal - experimental, translational and clinical.

Clinical and immunological findings in patients with concurrent MS and autoimmune thyroid disease

M. Pender, K. Tan, J. Greer, 2004 .

Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis

L. Haupt, R. Lea, L. Griffiths, 2006, Brain Research Bulletin.

Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes

S. Burrows, M. Pender, P. Csurhes, 2011, BMC neurology.

Saliva-derived DNA performs well in large-scale, high-density SNP microarray studies

Marilyn, Merriman, Booth, 2017 .

Role of single amino acids in the recognition of a T cell epitope.

A. Suhrbier, S. Rodda, P. Ho, 1991, Journal of Immunology.

Circulating brain derived neurotrophic factor (BDNF) and frequency of BDNF positive T cells in peripheral blood in human ischemic stroke: Effect on outcome

P. Mccombe, Jun Yan, J. Greer, 2015, Journal of Neuroimmunology.

T cells from patients with Guillain-Barré syndrome produce interferon-gamma in response to stimulation with the ganglioside GM1

P. Mccombe, P. Csurhes, 2010, Journal of clinical neuroscience.

Strains of Epstein-Barr virus infecting multiple sclerosis patients

L. Bromham, R. Brennan, J. Burrows, 2010, Multiple sclerosis.

Study of leukemia inhibitory factor polymorphism within an Australian multiple sclerosis population

L. Griffiths, M. Pender, J. Mackenzie, 2009, Journal of the Neurological Sciences.

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

Katherine K. Matthews, S. Burrows, Corey Smith, 2018, JCI insight.